News | March 24, 2025
Briefs: Alembic Pharmaceuticals and Shelter Pharma
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Alembic Pharma's Bioequivalence facility
USFDA inspection at Emcure Pharmaceuticals API facility
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Subscribe To Our Newsletter & Stay Updated
